newsfilter
← Latest News
Business Wire·

Early Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma's Deltacel-01 Clinical Trial

Favorable Safety and Tolerability also Observed Kiromic BioPharma, Inc. (OTCQB:KRBP) ("Kiromic" or the "Company") reports early efficacy results showing primary lung tumor stabilization and the complete disappearance